Twenty-six-week oral toxicity study of TCV-116 in rats

Japanese Pharmacology and Therapeutics

Volumn 24, Issue SUPPL. 6, 1996, Pages 49-68

  Nishida, Nobuyuki ^b   Sato, Keiichiro ^b   Sato, Shuzo ^b   Ishimura, Yoshimasa ^b   Chatani, Fumio ^b   Mitani, Masayoshi ^a  

^a Drug Safety Research Laboratories   (Japan)

^b Pharmacokin Research Laboratories

Author keywords

26 Week toxicity; Angiotensin II receptor type 1 antagonist; Rat; TCV 116

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CANDESARTAN HEXETIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BLOOD TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; FEMALE; HISTOPATHOLOGY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STOMACH MUCOSA LESION; TOXICITY TESTING;

EID: 0029814446     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Shibouta Y et al : Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (±)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). J Pharmacol Exp Ther 266 : 114, 1993
2. Inada Y et al : Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (±)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl] -1H -benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. J Pharmacol Exp Ther 268 : 1540, 1994
3. Snedecor GW, Cochran WG : Statistical Methods. 7th ed, Iowa State University Press, Ames, Iowa, 1980
4. Dunnett CW : A multiple comparison procedure for comparing several treatments with a control. J Am Statist Assoc 50 : 1096, 1955
5. Dunnett CW : New tables for multiple comparison with a control. Biometrics 20 : 482, 1964
6. Kruskal WH, Wallis WA : Use of ranks in one-criterion variance analysis. J Am Statist Assoc 47 : 583, 1952
7. Wada T et al : Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone. Eur J Pharmacol 253 : 27, 1994
8. Gould AB et al : Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats. Eur J Pharmacol 181 : 225, 1990
9. 1] angiotensin II. Am J Physiol 236 : F252, 1979
10. Hall JE et al : Control of filtration rate by renin-angiotensin system. Am J Physiol 233 : F366, 1977
11. Hall JE et al : Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Fed Proc 45 : 1413, 1986
12. Mori T et al : Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneous hypertensive rats. Jpn Circ J 59 : 624, 1995
13. 16)
14. Kamiya A, Togawa T : Adaptive regulation of wall shear stress to flow changes in the canine carotid artery. Am J Physiol 239 : H14, 1980
15. Masuda H et al : Artery wall restructuring in response to increased flow. Surgical Forum 40 : 285, 1989
16. Masuda H et al : Effects of endothelial denuation in flow-induced arterial dilatation. Frontiers Med Biol Eng 5 : 57, 1993